Palatin Technologies Inc To Host Key Opinion Leader Webinar Transcript
Good morning, and welcome to the Palatin Technologies KOL event. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Palatin website following the conclusion of the event.
I'd now like to turn the call over to Carl Spana, Chief Executive Officer of Palatin Technologies. Please go ahead, Carl.
Thank you, Tara. I'd like to welcome everyone to today's event.
Can you please go to the next slide? So as a forward-looking statement, we are a publicly traded company. We trade on the NYSE AMEX under the symbol PTM. So this just tells you that you should go look at our filings with the Securities and Exchange Commission.
So the next slide. Great. We are very excited today to talk to you about our PL9643 treatment for dry eye disease, which we believe, based on its excellent ocular tolerability, its broad efficacy, has the potential to become a leading treatment for dry eye disease.
Before we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |